AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Jul 31 2020
Dr. Anthony Fauci told a House of Representatives committee Friday that a COVID-19 coronavirus vaccine would likely be created by the end of the year, and widely distributed to Americans in 2021.
Some voices examined how people who oppose the use of vaccines may react when the coronavirus treatment is distributed to the masses; others focused on the billions of dollars the U.S. isThe Hill MarketWatch The Atlantic
Dec 16 2020
President-elect Joe Biden and Vice President Mike Pence are set to publicly receive the COVID-19 coronavirus vaccine soon. According to the White House, the vice president and Second Lady Karen Pence, along with Surgeon General Jerome Adams, will receive the vaccine on Friday to "build confidence among the American people.” CNN reported that Biden, who said he would follow the recommendationsHuffPost Wall Street Journal (News) The Blaze
Jul 27 2020
In partnership with the National Institutes of Health, biotechnology company Moderna plans to enroll roughly 30,000 subjects in Phase 3 of its COVID-19 coronavirus vaccine trial. The Biomedical Advanced Research and Development Authority have awarded Moderna another $472 million to fill the gap in needed funds. This brings the company's U.S.-based financial backing to roughly $955 million.The Boston Globe CNET Newsmax (News)
Apr 11 2020
As coronavirus deaths in the U.S. and around the world continue to mount, scientists in various countries are racing to develop a vaccine for COVID-19. Researchers in England have reported success with a vaccine being developed there, saying it could be made available to the public as early as September. Other countries, including Israel and the U.S., are also making progress.
CoverageNew York Times (News) New York Post (News) Wired
May 18 2020
Moderna Inc., a biotech company based in Massachusetts, is reporting positive interim data in the first phase of a COVID-19 coronavirus vaccine trial, as immune responses are similar to that in people who had recovered from the disease.
The company is about to begin a phase two trial and hopes to start a phase three trial in July.Newsmax (News) The Hill Washington Post
Jul 20 2020
According to newly released data, Oxford University's trials on the COVID-19 coronavirus vaccine have produced strong immune responses from subjects. This was the first trial conducted on humans; Oxford is working in tandem with pharmaceutical company AstraZeneca.
Coverage on the matter was generally uniform, irrespective of political leanings. Some voices, including those of worldNational Review HuffPost Reuters
Dec 02 2020
Promising results from clinical trials of three coronavirus vaccines have brought new hope for ending the pandemic. But a vaccine, or a combination of vaccines, will not be effective if people refuse to take it.
Experts estimate that at least 60 percent of Americans will need to be vaccinated to stop the virus from spreading to the rest of the population. The question of how to achieveYahoo! The 360
Aug 08 2022
Parents are having their say about the Covid-19 vaccines for children under 5, and for most, the answer so far is no.
More than a month after the U.S. Centers for Disease Control and Prevention recommended shots for about 17.4 million children ages 6 months through 4 years, about 4% to 5% of them have received a shot, according to the most recent agency data and population estimatesWall Street Journal (News)
Sep 03 2020
All of a sudden, it feels like we're hurtling toward a coronavirus vaccine — with the first doses potentially being administered before the 2020 election.
Why it matters: The question of whether politics influence the Trump administration's actions looms larger than ever. Just as important is the question of whether we'll be ready for this complicated effort in less than two months.Axios
Apr 11 2020
RESEARCHERS AROUND THE world are toiling to develop a vaccine for the coronavirus. But the creation of a working vaccine that can be safely distributed to a broad population requires a tremendous amount of rigor and caution, so the process is likely to take at least a year. WIRED staff writer Megan Molteni has covered the novel coronavirus outbreak since the virus was first identified in earlyWired